Latest Breaking News On - Rare pediatric disease designation - Page 6 : comparemela.com

Belgium-based EXO Biologics raises €16M to harness the therapeutic potential of exosomes

Liège-based EXO Biologics, a clinical-stage biotech company, announced that it has secured a total of up to €16M in Series A funding.

Waals gewestEuropean medicines agencyPublic service of walloniaBelgian familyPublic serviceTechnological innovation partnershipAdvanced therapy medicinal productsWalloon recovery planHugues wallemacqChief executive officerBronchopulmonary dysplasiaRare pediatric disease designationOrphan drug designation

McKesson : OJEMDA FDA Approved for Pediatric Low Grade Glioma

CARY, N.C., April 26, 2024 -Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by Day One Biopharmaceuticals, as a limited.

George paschalSpecialty solutionsDrug administrationSarah cannon research instituteUs oncology networkBusiness development for biologicsMckesson provider solutionsMckesson corporationUs oncology researchDay one biopharmaceuticalsRare pediatric disease designationBusiness developmentDay oneMckesson oncologySarah cannon research

FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease

/PRNewswire/ Medivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

United statesMagnus christensenRare pediatric disease designationOrphan drug designationPerthes diseasePriority review voucherNasdaq stockholmSmall cap

Medivir (MVIR) Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for MIV-711

Medivir (MVIR) Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for MIV-711
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMagnus christensenJens lindbergRare pediatric disease designationOrphan drug designationPerthes diseasePriority review voucher

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesPuerto ricoNorth carolinaAlbertd friesenVenture exchangeRegulation services providerMarley drug incMedicure pharma incExchange commissionGeneric drug programMedicure international incDrug administrationEuropean medicines agencyMedicure incFast trackRare pediatric disease designation